Breakthrough Gene Tech Attracts Investors Amid Patent Dispute
Companies are seeking to capitalize on a hot new gene technology, though a high-stakes patent dispute has yet to been settled. The gene-editing tool, known as Crispr-Cas9, serves as a kind of multipurpose molecular scissors ... read more
No comments yet. Be the first.
Search Advertising Perspectives